The goal of the UAB Comprehensive Sickle Cell Center is to develop new strategies to treat, and, ultimately, cure sickle cell disease. UAB's Comprehensive Sickle Cell Center Red Cell Diagnostic and Reference Laboratory will play an important role in providing the comprehensive diagnosis of red blood cell abnormalities and in providing a support for the basic and clinical studies outlined in this UAB CSCC application. The UAB CSCC Hemoglobin Diagnostic Laboratory provides state-of-the-art diagnosis of various genotypes constituting the spectrum of sickle cell disease. The UAB CSCC laboratory is the reference lab for the Alabama Neonatal Screening Program for Sickle Cell Disease. The laboratory also provides further testing and diagnosis for patients attending the Alabama Public Health Maternity and Family Planning Clinics. Similar services are provided to patients presenting to private physicians, clinics and laboratories throughout the state. The Diagnostic lab also receives samples from other states in the Southeast and other regions of the country for the determination of variants of sickle cell disease, other hemoglobinopathies and other congenital blood cell disorders. These are the roles of the laboratory: (1) provide up-to-date diagnostic service for all clinics; (2) analyze the blood of transgenic animals and perform analytical assays as needed by the Basic and Clinical Projects of UAB CSCC; (3) train hematology fellows and residents in Clinical Pathology in the diagnosis of hemoglobinopathies and in the interpretation of laboratory data; and (4) continue to serve as a reference lab for the State Neonatal Hemoglobinopathy Laboratory. To date, the laboratory activity has resulted in 74 original publications (the complete list in enclosed in the application) authored by the professional personnel of the lab. This has resulted in defining hew disease states, new genetic variants and clinically important interactions of multiple genetic variants of hemoglobin.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL058418-03
Application #
6325967
Study Section
Project Start
2000-04-01
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$162,688
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Coats, Mamie T; Benjamin, W H; Hollingshead, S K et al. (2005) Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae. Vaccine 23:4257-62
Telfair, Joseph; Alexander, Leah R; Loosier, Penny S et al. (2004) Providers' perspectives and beliefs regarding transition to adult care for adolescents with sickle cell disease. J Health Care Poor Underserved 15:443-61
Aslan, Mutay; Ryan, Thomas M; Townes, Tim M et al. (2003) Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 278:4194-204
Briles, David E; Hollingshead, Susan K; Paton, James C et al. (2003) Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 188:339-48
Liu, Enli; Jelinek, Jaroslav; Pastore, Yves D et al. (2003) Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 101:3294-301
Lim, Dong Gun; Sweeney, Scott; Bloodsworth, Allison et al. (2002) Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc Natl Acad Sci U S A 99:15941-6
Coles, Barbara; Bloodsworth, Allison; Eiserich, Jason P et al. (2002) Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem 277:5832-40
Coles, Barbara; Bloodsworth, Allison; Clark, Stephen R et al. (2002) Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91:375-81
Robinson, D Ashley; Briles, David E; Crain, Marilyn J et al. (2002) Evolution and virulence of serogroup 6 pneumococci on a global scale. J Bacteriol 184:6367-75
O'Donnell, V B; Freeman, B A (2001) Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 88:12-21

Showing the most recent 10 out of 22 publications